Skip to content

Generate Biomedicines, Inc. GENB Total Liabilities & Equity

Total Liabilities & Equity at other companies

MYR Group logo
MYR GroupMYRG
$1.67B+9.9%
First American Financial logo
First American FinancialFAF
$17.94B+15.7%
Dolby Laboratories, Inc. logo
Dolby Laboratories, Inc.DLB
$3.25B+0.6%
Liberty Global logo
Liberty GlobalLBTYB
$21.88B-15.8%
Mirion Technologies logo
Mirion TechnologiesMIR
$3.54B+34.7%
Spire logo
SpireSR
$14.67B+29.3%

Other financials

Income statement

See full
Revenue$7.2M-18.1%
Operating income-$64.1M-33.1%
Net income-$61.4M-47.4%
EPS (diluted)-$1.07+34.0%

Balance sheet

See full
Cash & equivalents$160.6M-27.2%
Total debt$65.6M
Total equity$514.8M+209%
Total assets$625.7M

Cash flow

See full
Operating cash flow-$80.4M-51.2%
CapEx$3.8M+403%
Free cash flow-$84.2M-56.1%

Valuation

See full
Market cap$1.86B
Enterprise value$1.76B

Returns & leverage

See full
Debt / equity0.1×
Current ratio9.2×

Where this comes from

Reported directly by Generate Biomedicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's total liabilities & equity?
Generate Biomedicines, Inc. (GENB) reported total liabilities & equity of $625.74M in Q1 2026.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.